Development of an analysis pipeline characterizing multiple hypervariable regions of 16S rRNA using mock samples. 16s rRNA multi-hypervariable region sequencing
收藏NIAID Data Ecosystem2026-03-09 收录
下载链接:
https://www.ncbi.nlm.nih.gov/bioproject/PRJEB10546
下载链接
链接失效反馈官方服务:
资源简介:
There is much speculation on which hypervariable region provides the highest bacterial specificity in 16S rRNA sequencing. The optimum solution to prevent bias and to obtain a comprehensive view of complex bacterial communities would be to sequence the entire 16S rRNA gene, however, this is not possible with second generation standard library design and short-read next-generation sequencing technology. This paper examines a new process using seven hypervariable or V regions of the 16S rRNA (six amplicons: V2, V3, V4, V67, V8 and V9) processed simultaneously on the Ion Torrent Personal Genome Machine (Life Technologies, Grand Island, NY). Four mock samples are amplified using the 16S Ion Metagenomics Kit ™ (Life Technologies) and their sequencing data is subjected to a novel analytical pipeline. The Kullback-Liebler divergence (DKL), a measure of the departure of the computed from the nominal bacterial distribution in the mock samples, was used to infer which region performed the best. Three different hypervariable regions, V2, V4 and V67 produced the lowest divergence compared to the known mock sample. The V9 region gave the highest (worst) average DKL while the V4 gave the lowest (best) average DKL. In addition to having a high DKL, the V9 region in both the forward and reverse directions performed the worst finding only 17% and 53% of the known family level bacteria, while results from the forward and reverse V4 region identified all 17 family level bacteria. The results of our analysis have shown that our sequencing methods using 6 hypervariable regions of the 16S rRNA and subsequent analysis is valid. This method also allowed for the assessment of how well each of the variable regions might perform simultaneously. Our findings will provide the basis for future work intended to assess microbial abundance at different time points throughout a clinical protocol.
创建时间:
2015-10-26



